# Adversarial Review — Orchestrator

- **id:** div-D-202606-1
- **review_type:** divergence-review
- **date:** 2026-07-06
- **cycle_number:** 1
- **strategy:** D
- **artifact under review:** Monthly_Fundamental.md (M1b, 2026-06)
- **attacker output:** Adversarial_Review_div-D-202606-1_attacker.md
- **divergence:** Technical ACTIVATE / Fundamental post-reconciliation DO-NOT-ACTIVATE

## Final verdict (one line)

**ACTIVATE (binding, UNCHANGED from prior state).** The post-reconciliation DNA is manufactured entirely by the mechanical `inflation_trend=reaccelerating AND policy_stance=hawkish` override firing on a raw fundamental call that ROSE to ACTIVATE; the higher-for-longer discount-rate regime the override encodes was **identical in May** (both axes UNCHANGED MoM), when the prior review adjudicated the same divergence and LIFTED the new-entry block — so nothing about the discount-rate path worsened this cycle while the recession leg cleared. Existing RTX/DIS run to thesis-invalidation; new-D-entry initiation permitted with a documented discount-rate-sensitivity caution in name selection/sizing.

## Theater-check flag

**DIVERGENT.** The orchestrator's assessment identified substantive independent issues rather than ratifying the attacker: it grades attacker weakness #2 as overstated and #4 as a non-sequitur, and it introduces the decisive consideration the attacker never raised — that the reflation/hawkish discount-rate regime the override encodes was present at the 2026-06-03 adjudication that lifted the block, making re-blocking on an unchanged regime inconsistent. Verdict binds (theater-check ≠ CONVERGENT).

## (a) Validity of each attacker weakness

1. **"Substantive fundamental case IS ACTIVATE — only a mechanical rule dissents."** — **VALID (Tier 1).** Factually correct against the artifact: the raw M1b call is ACTIVATE (line 85) and the DNA is produced solely by the reconciliation override (line 87). This is the load-bearing, correct observation.

2. **"Override mechanism (discount-rate compression) contradicted by observed −1% index / tight credit."** — **VALID but OVERSTATED (Tier 2).** The observation is accurate but the inference is horizon-mismatched: the override guards long-DURATION (12+ month) multi-year theses, and discount-rate compression on multi-year duration plays out over quarters/years, not in one month's IG OAS. One month of tight credit and a −1% index does not refute a multi-year duration-compression premise. The attacker demands intra-month evidence of a structural, slow-acting mechanism — a category error. This is the orchestrator's principal divergence from the attacker.

3. **"Override fires on stale (May-vintage) inflation while forward oil signal is disinflationary."** — **VALID but a TIMING argument (Tier 2).** Correct that the override keys off M1a's `reaccelerating` axis while the artifact flags oil's forward-disinflationary retreat (line 25). But the rule is mechanical on the axis value M1a scored, and next month's M1a re-scoring incorporates the oil disinflation if it persists. This argues "wait one print," not "the override is wrong this month."

4. **"Blocking new D entries when the recession leg just REVERSED is backwards."** — **PARTIAL THEATER / NON-SEQUITUR (Tier 3).** This conflates two distinct legs. D's raw ACTIVATE already reflects the recession-leg reversal; the override is about the *discount-rate* leg (reflation/hawkish), a different structural risk. The override is not "blocking because of recession" — it never invoked recession. The attacker's framing scores a rhetorical point against a claim the artifact does not make.

5. **"Re-litigation of an already-adjudicated flip with no new fundamental evidence for DNA."** — **VALID (Tier 1).** Correct and important: net final call is UNCHANGED (line 90), the prior review rejected the flip-to-DNA, and the only new fundamental evidence (growth re-firm) strengthens ACTIVATE. Nothing argues the multi-year environment worsened.

## (b) Theater in the attacker output

Weakness #4 is the clearest instance of generic-sounding overreach: it attacks a recession-based rationale the override never asserts. Weakness #2's rhetorical force ("the market is not pricing the discount-rate derating") slightly overstates a horizon-mismatched point. Otherwise the attacker is well-anchored to specific artifact lines — not theater on balance.

## (c) Weaknesses the attacker missed

- **Immutability boundary.** The reconciliation override is an immutable mid-experiment mechanical rule; the divergence review resolves the *activation state*, not the fundamental call — it neither can nor need overturn the rule. The attacker argued as if the override itself were on trial.
- **Same-regime-as-prior-cycle (decisive).** The reaccelerating-inflation + hawkish-policy discount-rate regime the override encodes was present in May too (both axes UNCHANGED MoM per the artifact's delta table; the artifact concedes the override was "precondition-satisfied in May"). The 2026-06-03 review adjudicated that exact regime and lifted the new-entry block. The override "firing" this cycle is a mechanical artifact of the raw call crossing UP into ACTIVATE — not new adverse discount-rate information. This is the orchestrator's decisive independent point and it *strengthens* the attacker's conclusion via a route the attacker did not take.
- **Narrow practical stakes.** Existing RTX/DIS run to invalidation regardless; the activation state governs only NEW long-horizon initiation, so the discount-rate concern is properly a name-selection/sizing caution, not a blanket block.

## (d) Reasoning and binding decision

The attacker's core is correct (weaknesses 1, 5): the DNA is override-manufactured, the raw case is ACTIVATE, and the recession leg — D's dominant structural threat — has cleared. The attacker's weakest arguments (2, 4) demand intra-month evidence of a multi-year mechanism and attack a recession rationale the override never made; the orchestrator diverges there. But the genuinely un-refuted concern — higher-for-longer discount-rate compression on NEW long-duration theses — does not bind the activation state here because that regime was *already in place* at the prior adjudication that lifted the new-entry block, and nothing about it worsened this cycle (growth actually improved). Re-blocking new entries now, on strictly-improved fundamentals and an unchanged discount-rate regime, would be arbitrary and inconsistent with the 2026-06-03 binding decision.

**Binding activation state: ACTIVATE — UNCHANGED.** Existing D positions (RTX, DIS) continue to thesis-invalidation under router-deactivation-does-not-force-exits. New-D-entry initiation remains permitted (block stays lifted), with the discount-rate/higher-for-longer path documented as a name-selection and sizing caution (favor lower-duration, cash-generative multi-year theses; size conservatively) and handled by each thesis's own invalidation criteria — not by an activation block.

## Action taken

- `events.regime_events` (scope `STRATEGY_ACTIVATION`, key `D`): binding state `ACTIVATE` written, superseding the M4 2026-07-01 PENDING row; theater_check DIVERGENT; source_review_ref this orchestrator review.
- Verdict does not differ from the prior binding state (ACTIVATE, block lifted) → no `events.decision_log` flip entry (per AR_orc protocol; the review outcome is recorded in `events.adversarial_reviews`).
- No orders staged; no calendar events.
